Taysha Gene Therapies
TSHA
#7797
Rank
C$0.36 B
Marketcap
$1.80
Share price
-9.75%
Change (1 day)
-53.16%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2023 (TTM): -$3.10

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -$3.28. In 2022 the company made an earnings per share (EPS) of -$5.45 an increase over its 2021 EPS that were of -$6.64.

EPS history for Taysha Gene Therapies from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.10-43.07%
2022-$5.45-17.93%
2021-$6.6469.11%
2020-$3.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.12-4.80%๐Ÿ‡บ๐Ÿ‡ธ USA